N-Methyl-D-aspartate receptor antagonists enhance the head-twitch response, a 5-hydroxytryptamine2 receptor-mediated behaviour, in reserpine-treated mice

J Pharm Pharmacol. 2000 Jun;52(6):717-22. doi: 10.1211/0022357001774390.

Abstract

In this study, N-methyl-D-aspartate (NMDA)-receptor antagonists enhanced the head-twitch response induced by 5-hydroxytryptamine (5-HT) in reserpine-treated mice. To minimize the risk of any indirect involvement of NMDA-receptor antagonists (D(-)-2-amino-5-phosphonopentanoic acid (AP-5), D(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid (CPP), (+)-5-methyl-10,11-dihydroxy-5H-dibenzo-[a,d]-cyclohepten-5,10-imi ne (MK-801), ketamine, dextrorphan and dextromethorphan) with 5-HT neurones, vesicle stores of monoamines, especially 5-HT, were depleted with reserpine. In addition, the enhancement of 5-HT-induced head-twitch response was inhibited by apomorphine and NMDA as well as ritanserin in reserpine-treated mice. These results support our previous conclusion that NMDA receptors play important roles in the glutamatergic modulation of 5-HTergic function at the postsynaptic 5-HT2 receptors in mice.

MeSH terms

  • Adrenergic Uptake Inhibitors / pharmacology*
  • Animals
  • Behavior, Animal
  • Glutamine / pharmacology
  • Head
  • Male
  • Mice
  • Mice, Inbred ICR
  • Movement / drug effects*
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / physiology*
  • Receptors, Serotonin / drug effects
  • Receptors, Serotonin / physiology
  • Reserpine / pharmacology*

Substances

  • Adrenergic Uptake Inhibitors
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Serotonin
  • Glutamine
  • Reserpine